Anti-OAS1 antibody [EPR24824-162]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal OAS1 antibody. Suitable for IP, Flow Cyt (Intra), WB and reacts with Human samples. Cited in 5 publications.
View Alternative Names
OIAS, OAS1, 2'-5'-oligoadenylate synthase 1, (2-5')oligo(A) synthase 1, 2-5A synthase 1, E18/E16, p46/p42 OAS
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-OAS1 antibody [EPR24824-162] (AB272492)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized 293T (Human embryonic kidney epithelial cell, left) / Daudi (Human Burkitt's lymphoma lymphoblast, right) cells labelling OAS1 with ab272492 at 1/50 dilution (1ug)/ red (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody. Negative control : 293T(PMID : 19923450).
- IP
Lab
Immunoprecipitation - Anti-OAS1 antibody [EPR24824-162] (AB272492)
OAS1 was immunoprecipitated from 0.35 mg NCI-H460 (human Large Cell Lung Cancer epithelial cell) whole cell lysate 10 ug with ab272492 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab272492 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : NCI-H460 (human Large Cell Lung Cancer epithelial cell) whole cell lysate 10 ug
Lane 2 : ab272492 IP in NCI-H460 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab272492 in NCI-H460 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 32 seconds
All lanes:
Immunoprecipitation - Anti-OAS1 antibody [EPR24824-162] (ab272492)
Predicted band size: 46 kDa
false
- WB
Lab
Western blot - Anti-OAS1 antibody [EPR24824-162] (AB272492)
Blocking buffer and concentration : Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBS Diluting buffer and concentration : Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBST Lysates/proteins at 20 µg per lane. Performed under reducing conditions. False colour image of Western blot : Anti-OAS1antibody [EPR24824-162] (ab272492) staining at 1/1000 dilution, shown in green; Mouse anti-alpha Tubulin antibody [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab272492 was shown to bind specifically to OAS1. A band was observed at 42 kDa in wild-type HeLa cell lysates with no signal observed at this size in OAS1 knockout cell lysates (ab259009) (knockout cell line ab265578). To generate this image, wild-type and OAS1 knockout HeLa cell lysates were analyzed. First, samples were run on an SDS-PAGE gel then transferred onto an immobilon-FL PVDF membrane. Membranes were blocked in Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBS before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/10000 dilution.
Lanes 1 - 4:
Western blot - Anti-OAS1 antibody [EPR24824-162] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/oas1-antibody-epr24824-162-bsa-and-azide-free-ab284864'>ab284864</a>) at 1/1000 dilution
Lanes 1 - 4:
Western blot - Anti-OAS1 antibody [EPR24824-162] (ab272492) at 1/1000 dilution
Lane 1:
Wild-type HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Wild-type HeLa treated with 1000 U/ml IFN beta for 28 hours, whole cell lysate at 20 µg
Lane 3:
OAS1 knockout HeLa whole cell lysate at 20 µg
Lane 4:
OAS1 knockout HeLa treated with 1000 U/ml IFN beta for 28 hours, whole cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution
Lanes 1 - 4:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 46 kDa
Observed band size: 42 kDa
false
- WB
Lab
Western blot - Anti-OAS1 antibody [EPR24824-162] (AB272492)
Blocking and diluting buffer and concentration : 5% NFDM/TBSTThe molecular weight observed is consistent with what has been described in the literature (PMID : 25205466).
Negative control : LNCaP, 293T (PMID : 26997919).
Exposure time : Lane 1-2 : 3 minutes Lane 3-6 : 37 seconds
All lanes:
Western blot - Anti-OAS1 antibody [EPR24824-162] (ab272492) at 1/1000 dilution
Lane 1:
Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 2:
HeLa treated with /ml IFN alpha 1 for 16 hours, whole cell lysate 20
Lane 3:
NCI-H460 (human Large Cell Lu Cancer epithelial cell) whole cell lysate 20
Lane 4:
Daudi (human Burkitts lymphoma lymphoblast) whole cell lysate
Lane 5:
LNCaP (human prostate carcinoma epithelial cell) whole cell lysate
Lane 6:
293T (human embryonic kidney epithelial cell) whole cell lysate
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 46 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The creation of 2'-5'-linked oligoadenylates by OAS1 is essential in activating RNase L an enzyme that degrades viral and cellular RNA to impede viral replication. OAS1 does not operate as part of a larger protein complex but functions independently to mediate antiviral activities. It has been observed that upon viral infection the levels of OAS1 increase enhancing the interferon response and cytokine signaling.
Pathways
OAS1 plays a significant role in the interferon signaling pathway and innate immune response pathways. Within these pathways OAS1 interacts with other proteins such as RNase L and is also associated with STAT1 a critical mediator of the cellular response to interferons. The function of OAS1 within these pathways highlights its importance in modulating immune responses to pathogens.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Journal of virology 99:e0156724 PubMed39601590
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 15:1343805 PubMed39403387
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 300:107783 PubMed39303913
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 97:e0121723 PubMed37815352
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:793517 PubMed34975898
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com